208 related articles for article (PubMed ID: 33305634)
1. dPCR application in liquid biopsies: divide and conquer.
Moreno-Manuel A; Calabuig-Fariñas S; Obrador-Hevia A; Blasco A; Fernández-Díaz A; Sirera R; Camps C; Jantus-Lewintre E
Expert Rev Mol Diagn; 2021 Jan; 21(1):3-15. PubMed ID: 33305634
[No Abstract] [Full Text] [Related]
2. Next-generation sequencing for tumor mutation quantification using liquid biopsies.
Provencio M; Pérez-Barrios C; Barquin M; Calvo V; Franco F; Sánchez E; Sánchez R; Marsden D; Cristóbal Sánchez J; Martin Acosta P; Laza-Briviesca R; Cruz-Bermúdez A; Romero A
Clin Chem Lab Med; 2020 Jan; 58(2):306-313. PubMed ID: 31469650
[TBL] [Abstract][Full Text] [Related]
3. Cross-sectional analysis of circulating tumor DNA in primary colorectal cancer at surgery and during post-surgery follow-up by liquid biopsy.
Allegretti M; Cottone G; Carboni F; Cotroneo E; Casini B; Giordani E; Amoreo CA; Buglioni S; Diodoro M; Pescarmona E; Zazza S; Federici O; Zeuli M; Conti L; Cigliana G; Fiorentino F; Valle M; Giacomini P; Spinella F
J Exp Clin Cancer Res; 2020 Apr; 39(1):69. PubMed ID: 32312295
[TBL] [Abstract][Full Text] [Related]
4. Toward liquid biopsies in cancer treatment: application of circulating tumor DNA.
Barlebo Ahlborn L; Østrup O
APMIS; 2019 May; 127(5):329-336. PubMed ID: 30784124
[TBL] [Abstract][Full Text] [Related]
5. Digital PCR: A Reliable Tool for Analyzing and Monitoring Hematologic Malignancies.
Coccaro N; Tota G; Anelli L; Zagaria A; Specchia G; Albano F
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32365599
[TBL] [Abstract][Full Text] [Related]
6. Monitoring of somatic mutations in circulating cell-free DNA by digital PCR and next-generation sequencing during afatinib treatment in patients with lung adenocarcinoma positive for EGFR activating mutations.
Iwama E; Sakai K; Azuma K; Harada T; Harada D; Nosaki K; Hotta K; Ohyanagi F; Kurata T; Fukuhara T; Akamatsu H; Goto K; Shimose T; Kishimoto J; Nakanishi Y; Nishio K; Okamoto I
Ann Oncol; 2017 Jan; 28(1):136-141. PubMed ID: 28177428
[TBL] [Abstract][Full Text] [Related]
7. Droplet-Based Digital PCR: Application in Cancer Research.
Perkins G; Lu H; Garlan F; Taly V
Adv Clin Chem; 2017; 79():43-91. PubMed ID: 28212714
[TBL] [Abstract][Full Text] [Related]
8. Unlocking the future of cancer diagnosis - promises and challenges of ctDNA-based liquid biopsies in non-small cell lung cancer.
Reina C; Šabanović B; Lazzari C; Gregorc V; Heeschen C
Transl Res; 2024 Jun; 272():41-53. PubMed ID: 38838851
[TBL] [Abstract][Full Text] [Related]
9. Detection of circulating tumor DNA (ctDNA) by digital droplet polymerase chain reaction (dd-PCR) in liquid biopsies.
Valpione S; Campana L
Methods Enzymol; 2019; 629():1-15. PubMed ID: 31727235
[TBL] [Abstract][Full Text] [Related]
10. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients.
Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P
Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141
[TBL] [Abstract][Full Text] [Related]
11. Emerging digital PCR technology in precision medicine.
Zhang L; Parvin R; Fan Q; Ye F
Biosens Bioelectron; 2022 Sep; 211():114344. PubMed ID: 35598553
[TBL] [Abstract][Full Text] [Related]
12. Liquid biopsy: unlocking the potentials of cell-free DNA.
Chu D; Park BH
Virchows Arch; 2017 Aug; 471(2):147-154. PubMed ID: 28466157
[TBL] [Abstract][Full Text] [Related]
13. Genomic Landscape of Liquid Biopsy for Hepatocellular Carcinoma Personalized Medicine.
Moldogazieva NT; Zavadskiy SP; Terentiev AA
Cancer Genomics Proteomics; 2021; 18(3 Suppl):369-383. PubMed ID: 33994362
[TBL] [Abstract][Full Text] [Related]
14. Liquid Biopsy Hotspot Variant Assays: Analytical Validation for Application in Residual Disease Detection and Treatment Monitoring.
Hallermayr A; Benet-Pagès A; Steinke-Lange V; Mansmann U; Rentsch M; Holinski-Feder E; Pickl JMA
Clin Chem; 2021 Nov; 67(11):1483-1491. PubMed ID: 34392332
[TBL] [Abstract][Full Text] [Related]
15. Applications of Digital Polymerase Chain Reaction (dPCR) in Molecular and Clinical Testing.
Wainman LM; Sathyanarayana SH; Lefferts JA
J Appl Lab Med; 2024 Jan; 9(1):124-137. PubMed ID: 38167753
[TBL] [Abstract][Full Text] [Related]
16. The Role of BEAMing and Digital PCR for Multiplexed Analysis in Molecular Oncology in the Era of Next-Generation Sequencing.
Denis JA; Guillerm E; Coulet F; Larsen AK; Lacorte JM
Mol Diagn Ther; 2017 Dec; 21(6):587-600. PubMed ID: 28667577
[TBL] [Abstract][Full Text] [Related]
17. Validation of the digital PCR system in tyrosine kinase inhibitor-resistant EGFR mutant non-small-cell lung cancer.
Masago K; Fujita S; Hata A; Okuda C; Yoshizumi Y; Kaji R; Katakami N; Hirata Y; Yatabe Y
Pathol Int; 2018 Mar; 68(3):167-173. PubMed ID: 29341374
[TBL] [Abstract][Full Text] [Related]
18. Droplet-based digital PCR and next generation sequencing for monitoring circulating tumor DNA: a cancer diagnostic perspective.
Postel M; Roosen A; Laurent-Puig P; Taly V; Wang-Renault SF
Expert Rev Mol Diagn; 2018 Jan; 18(1):7-17. PubMed ID: 29115895
[TBL] [Abstract][Full Text] [Related]
19. Molecular tumor analysis and liquid biopsy: a feasibility investigation analyzing circulating tumor DNA in patients with central nervous system lymphomas.
Hickmann AK; Frick M; Hadaschik D; Battke F; Bittl M; Ganslandt O; Biskup S; Döcker D
BMC Cancer; 2019 Mar; 19(1):192. PubMed ID: 30823914
[TBL] [Abstract][Full Text] [Related]
20. The Emerging Role of Liquid Biopsies in Revolutionising Cancer Diagnosis and Therapy.
Shegekar T; Vodithala S; Juganavar A
Cureus; 2023 Aug; 15(8):e43650. PubMed ID: 37719630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
